相关实验视频

Updated: Jul 15, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.1K

在接受达普森治疗的COVID-19患者中检测甲血球血症

Fatima Chagani1, Asha Bansari2, Bhagwan Dass3

  • 1Department of Medicine, University of Florida, Gainesville, Florida, USA Fatima.Chagani@medicine.ufl.edu.

BMJ case reports
|January 10, 2024
PubMed
概括

甲血球血,一种影响氧气运输的疾病,可能发生在COVID-19患者身上. 这一案例突出显示了达素诱导的甲血球血红病,该病例发生在患有Pneumocystic jirovecii肺炎的患者身上.

关键词:
在 COVID-19 疫情中,血液学 (药物和药物)医疗管理医疗管理肺炎 (呼吸系统药物) 肺炎 (呼吸系统药物) 肺炎

更多相关视频

Minimal Erythema Dose MED Testing06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

41.7K
Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care14:28

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care

Published on: May 10, 2024

1.6K

相关概念视频

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.